Compare ADMA Biologics Inc (ADMA) vs Ferrari NV (RACE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Ferrari NV — how do they compare? ADMA Biologics Inc trades at $9.87 (market cap $2.22B), while Ferrari NV trades at $408.36 (market cap $71.67B). The key difference: Ferrari NV is far larger — about 32.3× ADMA Biologics Inc's market cap, and Ferrari NV pays a 1.04% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | RACE | |
|---|---|---|
Market Cap | $2.22B | $71.67B |
Sector | Health | Consumer Cyclical |
52-Week High | $20.38 | $504.09 |
52-Week Low | $7.60 | $314.63 |
Enterprise Value | $2.29B | $73.60B |
Dividend Yield | — | 1.04% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Ferrari NV
Ferrari engineers and manufactures some of the world's most expensive exotic sports cars. The Ferrari brand is synonymous with Formula One racing, exclusivity, Italian design, and state-of-the-art technology. Ferrari also has a captive finance company that provides funding for dealers and clients.
Read more on RACE →
